Literature DB >> 32416652

The diabetic foot ulcer.

Rebecca Reardon1, Dominic Simring2, Boyoung Kim3, James Mortensen4, Deepak Williams5, Anthony Leslie5.   

Abstract

BACKGROUND: Diabetic foot ulcers are associated with significant morbidity and mortality and can subsequently lead to hospitalisation and lower limb amputation if not recognised and treated in a timely manner.
OBJECTIVE: The aim of this article is to review the current evidence for preventing and managing diabetic foot ulcers, with the aim to increase clinicians' confidence in assessing and treating these complex medical presentations. DISCUSSION: All patients with diabetes should have an annual foot review by a general practitioner or podiatrist. A three-monthly foot review is recommended for any patient with a history of a diabetic foot infection. Assessment involves identification of risk factors including peripheral neuropathy and peripheral vascular disease, and examination of ulceration if present. It is essential to identify patients with diabetes who are 'at risk' of ulceration, assess for any early signs of skin breakdown, initiate appropriate management to prevent progression and refer the patient if indicated.

Entities:  

Year:  2020        PMID: 32416652     DOI: 10.31128/AJGP-11-19-5161

Source DB:  PubMed          Journal:  Aust J Gen Pract


  11 in total

1.  Magnetic Resonance Imaging Data Features to Evaluate the Efficacy of Compound Skin Graft for Diabetic Foot.

Authors:  Chunlei Wang; Xiaomei Yu; Ying Sui; Junhui Zhu; Bo Zhang; Yongtao Su
Journal:  Contrast Media Mol Imaging       Date:  2022-06-13       Impact factor: 3.009

2.  Associations between Nutrients and Foot Ulceration in Diabetes: A Systematic Review.

Authors:  Nada Bechara; Jenny E Gunton; Victoria Flood; Tien-Ming Hng; Clare McGloin
Journal:  Nutrients       Date:  2021-07-27       Impact factor: 6.706

Review 3.  Management of diabetic foot ulcers and the challenging points: An endocrine view.

Authors:  Hakan Doğruel; Mustafa Aydemir; Mustafa Kemal Balci
Journal:  World J Diabetes       Date:  2022-01-15

4.  Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Accelerate Diabetic Wound Healing via Ameliorating Oxidative Stress and Promoting Angiogenesis.

Authors:  Chenchen Yan; Yan Xv; Ze Lin; Yori Endo; Hang Xue; Yiqiang Hu; Liangcong Hu; Lang Chen; Faqi Cao; Wu Zhou; Peng Zhang; Guohui Liu
Journal:  Front Bioeng Biotechnol       Date:  2022-01-31

5.  Down-Regulation of miR-138 Alleviates Inflammatory Response and Promotes Wound Healing in Diabetic Foot Ulcer Rats via Activating PI3K/AKT Pathway and hTERT.

Authors:  Jian Wang; Xiaodan Zhao; Guichang Tian; Xiaochao Liu; Chengyan Gui; Lin Xu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-14       Impact factor: 3.249

Review 6.  A comprehensive review of methods based on deep learning for diabetes-related foot ulcers.

Authors:  Jianglin Zhang; Yue Qiu; Li Peng; Qiuhong Zhou; Zheng Wang; Min Qi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

Review 7.  Adipose-Derived Stem Cells for the Treatment of Diabetic Wound: From Basic Study to Clinical Application.

Authors:  Runzhu Liu; Ruijia Dong; Mengling Chang; Xiao Liang; Hayson Chenyu Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-11       Impact factor: 6.055

8.  Exosomes from mmu_circ_0001052-modified adipose-derived stem cells promote angiogenesis of DFU via miR-106a-5p and FGF4/p38MAPK pathway.

Authors:  Zun-Hong Liang; Nan-Fang Pan; Shi-Shuai Lin; Zhi-Yang Qiu; Ping Liang; Jun Wang; Zhi Zhang; Yun-Chuan Pan
Journal:  Stem Cell Res Ther       Date:  2022-07-23       Impact factor: 8.079

Review 9.  Bioactive Antimicrobial Peptides as Therapeutic Agents for Infected Diabetic Foot Ulcers.

Authors:  Jessica Da Silva; Ermelindo C Leal; Eugénia Carvalho
Journal:  Biomolecules       Date:  2021-12-17

10.  Production of an Animal Model of Semi-Yin and Semi-Yang Syndrome with Diabetic Ulcers and Study of Its Pathological and Metabolic Features.

Authors:  Yu Liu; Jian-Ping Shi; Wu Xiong; Yang Liu; Yu Yan; Chao-Qi Yin; Yu-Qi Jiao; Xi Zhang; Jian-Da Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.